Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo
- PMID: 12907650
Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo
Abstract
Alteration of the phenotype of breast cancers from estrogen-dependent to estrogen-independent growth often leads to the failure of antiestrogenic tumor therapies. We report that overexpression of vascular endothelial growth factor (VEGF) by estrogen-dependent MCF-7 breast cancer cells could abolish estrogen-dependent tumor growth in ovariectomized mice. In the absence of estrogen, MCF-7 VEGF-expressing tumors with increased vessel density showed growth kinetics similar to, or even greater than, that of parental MCF-7 tumors with estrogen supplementation. Overexpression of VEGF by MCF-7 cells or treatment on parental MCF-7 cells with recombinant VEGF also stimulated cell proliferation in culture. Our data suggest that VEGF stimulation of MCF-7 tumor angiogenesis and growth is mediated by both autocrine and paracrine mechanisms.
Similar articles
-
Cyr61 promotes breast tumorigenesis and cancer progression.Oncogene. 2002 Nov 21;21(53):8178-85. doi: 10.1038/sj.onc.1205682. Oncogene. 2002. PMID: 12444554
-
Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.J Natl Cancer Inst. 1995 Feb 1;87(3):213-9. doi: 10.1093/jnci/87.3.213. J Natl Cancer Inst. 1995. PMID: 7535859
-
Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.Cancer Res. 2002 Sep 1;62(17):4977-84. Cancer Res. 2002. PMID: 12208749
-
Transfected MCF-7 cells as a model for breast-cancer progression.Breast Cancer Res Treat. 1994;31(2-3):153-65. doi: 10.1007/BF00666149. Breast Cancer Res Treat. 1994. PMID: 7881095 Review.
-
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.Breast Cancer Res Treat. 1995;36(2):139-55. doi: 10.1007/BF00666036. Breast Cancer Res Treat. 1995. PMID: 8534863 Review.
Cited by
-
The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.Oncoscience. 2016 Jul 22;3(7-8):242-257. doi: 10.18632/oncoscience.314. eCollection 2016. Oncoscience. 2016. PMID: 27713913 Free PMC article.
-
Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis.Cancer Cell Int. 2010 Aug 19;10:28. doi: 10.1186/1475-2867-10-28. Cancer Cell Int. 2010. PMID: 20723262 Free PMC article.
-
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.Sci Rep. 2016 Dec 20;6:39460. doi: 10.1038/srep39460. Sci Rep. 2016. PMID: 27995973 Free PMC article.
-
Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway.Cancer Res. 2007 May 1;67(9):4254-63. doi: 10.1158/0008-5472.CAN-06-4100. Cancer Res. 2007. PMID: 17483337 Free PMC article.
-
Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer.Cancer Res. 2010 Apr 1;70(7):2655-64. doi: 10.1158/0008-5472.CAN-09-4373. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332242 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical